These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32102830)

  • 1. Repurposing infectious disease vaccines for intratumoral immunotherapy.
    Melero I; Gato M; Shekarian T; Aznar A; Valsesia-Wittmann S; Caux C; Etxeberrria I; Teijeira A; Marabelle A
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32102830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus.
    Meng Q; He J; Zhong L; Zhao Y
    Int J Med Sci; 2021; 18(11):2294-2302. PubMed ID: 33967605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.
    Guo Y; Chen Y; Liu X; Min JJ; Tan W; Zheng JH
    Cancer Lett; 2020 Jan; 469():102-110. PubMed ID: 31666180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral Immunotherapy: From Trial Design to Clinical Practice.
    Champiat S; Tselikas L; Farhane S; Raoult T; Texier M; Lanoy E; Massard C; Robert C; Ammari S; De Baère T; Marabelle A
    Clin Cancer Res; 2021 Feb; 27(3):665-679. PubMed ID: 32943460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade.
    Shekarian T; Sivado E; Jallas AC; Depil S; Kielbassa J; Janoueix-Lerosey I; Hutter G; Goutagny N; Bergeron C; Viari A; Valsesia-Wittmann S; Caux C; Marabelle A
    Sci Transl Med; 2019 Oct; 11(515):. PubMed ID: 31645452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Newman JH; Chesson CB; Herzog NL; Bommareddy PK; Aspromonte SM; Pepe R; Estupinian R; Aboelatta MM; Buddhadev S; Tarabichi S; Lee M; Li S; Medina DJ; Giurini EF; Gupta KH; Guevara-Aleman G; Rossi M; Nowicki C; Abed A; Goldufsky JW; Broucek JR; Redondo RE; Rotter D; Jhawar SR; Wang SJ; Kohlhapp FJ; Kaufman HL; Thomas PG; Gupta V; Kuzel TM; Reiser J; Paras J; Kane MP; Singer EA; Malhotra J; Denzin LK; Sant'Angelo DB; Rabson AB; Lee LY; Lasfar A; Langenfeld J; Schenkel JM; Fidler MJ; Ruiz ES; Marzo AL; Rudra JS; Silk AW; Zloza A
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1119-1128. PubMed ID: 31888983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Plasticity and Resistance to Immunotherapy.
    Horn LA; Fousek K; Palena C
    Trends Cancer; 2020 May; 6(5):432-441. PubMed ID: 32348738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition.
    Yuan J; Khilnani A; Brody J; Andtbacka RHI; Hu-Lieskovan S; Luke JJ; Diab A; Marabelle A; Snyder A; Cao ZA; Hodi FS
    Eur J Cancer; 2021 Nov; 157():493-510. PubMed ID: 34561127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC.
    Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S
    Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function.
    Beyranvand Nejad E; Labrie C; van der Sluis TC; van Duikeren S; Franken KLMC; Roosenhoff R; Arens R; van Hall T; van der Burg SH
    Int J Cancer; 2021 Jan; 148(1):211-225. PubMed ID: 32875568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression.
    Mohebbi A; Ebrahimzadeh MS; Baghban Rahimi S; Saeidi M; Tabarraei A; Mohebbi SR; Shirian S; Gorji A; Ghaemi A
    Virus Res; 2019 Feb; 261():72-80. PubMed ID: 30599161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment.
    Vitiello GAF; Ferreira WAS; Cordeiro de Lima VC; Medina TDS
    Front Immunol; 2021; 12():782852. PubMed ID: 34925363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy.
    Collins JM; Redman JM; Gulley JL
    Expert Rev Vaccines; 2018 Aug; 17(8):697-705. PubMed ID: 30058393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine.
    Smalley Rumfield C; Pellom ST; Morillon Ii YM; Schlom J; Jochems C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral immunotherapy: using the tumor as the remedy.
    Marabelle A; Tselikas L; de Baere T; Houot R
    Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity.
    Wang G; Chow RD; Bai Z; Zhu L; Errami Y; Dai X; Dong MB; Ye L; Zhang X; Renauer PA; Park JJ; Shen L; Ye H; Fuchs CS; Chen S
    Nat Immunol; 2019 Nov; 20(11):1494-1505. PubMed ID: 31611701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
    Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P
    BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live-attenuated Listeria-based immunotherapy.
    Rothman J; Paterson Y
    Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificially cloaked viral nanovaccine for cancer immunotherapy.
    Fusciello M; Fontana F; Tähtinen S; Capasso C; Feola S; Martins B; Chiaro J; Peltonen K; Ylösmäki L; Ylösmäki E; Hamdan F; Kari OK; Ndika J; Alenius H; Urtti A; Hirvonen JT; Santos HA; Cerullo V
    Nat Commun; 2019 Dec; 10(1):5747. PubMed ID: 31848338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.